“I'm not trying to trash or invalidate that study or its authors”
Trying? You did.
“I'm saying that from a scientific standpoint, the evidence for a reduction in opioid use in that study is not going to convince the CMS to approve RecoveryRx for reimbursement under the NOPAIN Act.”
Agree…as I posted before… “…What CMS will or will not accept is another matter. No one knows. I would think that the noted study would not suffice; not robust….”
Yet, that does not mean the results were insignificant given the one patient outlier event pushed at the expense of all the other patients for whom BIEL’s product showed amazing efficacy with opioid reduction.
News 
Market Data 
Discover 
AI
